Cerebral and Muscular Metastases From Prostate Adenocarcinoma Initially Depicted by 177 Lu-PSMA SPECT/CT

Clin Nucl Med. 2024 Mar 1;49(3):262-264. doi: 10.1097/RLU.0000000000005050. Epub 2024 Jan 24.

Abstract

Cerebral and muscular metastases from prostatic adenocarcinoma occur rarely. Patients who develop such metastatic pattern exhibit noticeable symptoms. Herein, we present a 68-year-old man diagnosed with metastatic castrate-resistant prostate cancer. The patient received multiple 177 Lu-PSMA cycles. After the last cycle, a posttreatment SPECT/CT suggested disease progression with uncommon metastatic pattern in the right temporal brain lobe and muscles. 68 Ga-PSMA PET/CT and brain MRI confirmed these findings. Surprisingly, the patient remained asymptomatic up until the conclusion of the follow-up, which lasted for 3 months. This case emphasizes the importance of posttreatment scintigraphic imaging when other biomarkers are inconclusive.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma* / diagnostic imaging
  • Aged
  • Dipeptides
  • Heterocyclic Compounds, 1-Ring
  • Humans
  • Lutetium
  • Male
  • Positron Emission Tomography Computed Tomography / methods
  • Prostate / pathology
  • Prostate-Specific Antigen
  • Prostatic Neoplasms* / diagnostic imaging
  • Prostatic Neoplasms* / pathology
  • Prostatic Neoplasms, Castration-Resistant* / diagnostic imaging
  • Prostatic Neoplasms, Castration-Resistant* / pathology
  • Radioisotopes*
  • Single Photon Emission Computed Tomography Computed Tomography
  • Treatment Outcome

Substances

  • Lutetium-177
  • Prostate-Specific Antigen
  • Lutetium
  • Heterocyclic Compounds, 1-Ring
  • Dipeptides
  • Radioisotopes